UNRESECTABLE CUTANEOUS MELANOMA
Clinical trials for UNRESECTABLE CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made vaccine trial targets advanced cancers
Disease control Recruiting nowThis early-stage study is testing a personalized vaccine designed to train the immune system to attack a patient's specific cancer. It is for adults with advanced breast cancer, melanoma, or non-small cell lung cancer that has continued to grow despite standard treatments. The ma…
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Cancer care comes home: trial tests if shots at home beat clinic visits
Disease control Recruiting nowThis study is testing whether giving a cancer immunotherapy treatment called nivolumab as an injection at home is a safe and practical alternative to receiving it at a clinic. It aims to see if home treatment reduces the burden of travel and time spent in medical facilities, pote…
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Could a morning shot fight cancer better?
Disease control Recruiting nowThis study is testing whether giving two immunotherapy drugs (ipilimumab and nivolumab) at specific times of day improves how well they work for advanced melanoma. Researchers want to see if receiving treatment in the morning, afternoon, or late afternoon leads to better survival…
Matched conditions: UNRESECTABLE CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC